AFRICA
GARCIA-ORAD CARLES
Investigador/a en el periodo 1990-2018
IDOIA
MARTIN GUERRERO
PROFESORADO AGREGADO
Publicaciones en las que colabora con IDOIA MARTIN GUERRERO (50)
2021
-
A Genome-Wide Study of Single-Nucleotide Polymorphisms in MicroRNAs and Further In Silico Analysis Reveals Their Putative Role in Susceptibility to Late-Onset Alzheimer’s Disease
Molecular Neurobiology, Vol. 58, Núm. 1, pp. 55-64
2020
-
Role of rs10406069 in miR-5196 in hyperdiploid childhood acute lymphoblastic leukemia
Epigenomics, Vol. 12, Núm. 22, pp. 1949-1955
-
Variability in Cerebrospinal Fluid MicroRNAs Through Life
Molecular Neurobiology, Vol. 57, Núm. 10, pp. 4134-4142
2019
-
Cell-free DNA as a biomarker in diffuse large B-cell lymphoma: A systematic review
Critical Reviews in Oncology/Hematology, Vol. 139, pp. 7-15
-
Variants in vincristine pharmacodynamic genes involved in neurotoxicity at induction phase in the therapy of pediatric acute lymphoblastic leukemia
Pharmacogenomics Journal, Vol. 19, Núm. 6, pp. 564-569
2018
-
Involvement of SNPs in miR-3117 and miR-3689d2 in childhood acute lymphoblastic leukemia risk
Oncotarget, Vol. 9, Núm. 33, pp. 22907-22914
-
Involvement of miRNA polymorphism in mucositis development in childhood acute lymphoblastic leukemia treatment
Pharmacogenomics, Vol. 19, Núm. 18, pp. 1403-1412
-
Mir-pharmacogenetics of Vincristine and peripheral neurotoxicity in childhood B-cell acute lymphoblastic leukemia
Pharmacogenomics Journal, Vol. 18, Núm. 6, pp. 704-712
-
Osteosarkoma pediatrikoarekiko suszeptibilitatean inplikatuta dauden aldaera genetikoak
Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 34, pp. 59-82
-
Pharmacoepigenetics in childhood acute lymphoblastic leukemia: Involvement of miRNA polymorphisms in hepatotoxicity
Epigenomics, Vol. 10, Núm. 4, pp. 409-417
-
Role of miRNAs in treatment response and toxicity of childhood acute lymphoblastic leukemia
Pharmacogenomics, Vol. 19, Núm. 4, pp. 361-373
-
Variants in the 14q32 miRNA cluster are associated with osteosarcoma risk in the Spanish population
Scientific Reports, Vol. 8, Núm. 1
2017
-
Confirmation of involvement of new variants at CDKN2A/B in pediatric acute lymphoblastic leukemia susceptibility in the Spanish population
PLoS ONE, Vol. 12, Núm. 5
-
Cytotoxic T lymphocyte-associated antigen 4 rs231775 polymorphism and osteosarcoma
Neoplasma, Vol. 64, Núm. 2, pp. 299-304
-
Genetic susceptibility in childhood acute lymphoblastic leukemia
Medical Oncology, Vol. 34, Núm. 10
-
MTHFR polymorphisms in childhood acute lymphoblastic leukemia: Influence on methotrexate therapy
Pharmacogenomics and Personalized Medicine, Vol. 10, pp. 69-78
-
PNPLA3 rs738409 and Hepatotoxicity in Children With B-cell Acute Lymphoblastic Leukemia: A Validation Study in a Spanish Cohort
Clinical Pharmacology and Therapeutics
-
Review of pharmacogenetics studies of L-asparaginase hypersensitivity in acute lymphoblastic leukemia points to variants in the GRIA1 gene
Drug Metabolism and Personalized Therapy, Vol. 32, Núm. 1, pp. 1-9
-
The miR-1206 microRNA variant is associated with methotrexate-induced oral mucositis in pediatric acute lymphoblastic leukemia
Pharmacogenetics and Genomics, Vol. 27, Núm. 8, pp. 303-306
2016
-
A systematic review and meta-analysis of MDM2 polymorphisms in osteosarcoma susceptibility
Pediatric Research, Vol. 80, Núm. 4, pp. 472-479